The Predictive Value of Serum DAO, HDC, and MMP8 for the Gastrointestinal Injury in the Early Stage of Acute Pancreatitis in an Animal Model and a Clinical Study
DOI: https://doi.org/10.2147/ijgm.s461352
IF: 2.145
2024-05-07
International Journal of General Medicine
Abstract:Ruoxi Cheng, 1, &ast Jie Wang, 1, &ast Qing Wu, 1 Peng Peng, 1 Guolin Liao, 1 Xiuping Luo, 1 Zhihai Liang, 2 Jiean Huang, 1, &ast Mengbin Qin 1, &ast 1 Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, People's Republic of China; 2 Department of Gastroenterology, the First Affiliated Hospital of Guangxi Medical University, Nanning, 530007, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jiean Huang; Mengbin Qin, Department of Gastroenterology, the Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, People's Republic of China, Email ; Purpose: This study was aimed at exploring the use of the acute gastrointestinal injury (AGI) grade and sensitive biomarkers to investigate gastrointestinal (GI) injury in early stage of acute pancreatitis (AP). Patients and Methods: The AGI grade was used to evaluate intestinal function. Any GI injury above grade I (grades II–IV) was considered as severe. An AP rat model was created by retrograde injection of 4% sodium taurocholate. The pancreatic and intestinal histopathology scores were calculated by hematoxylin-eosin staining. Human and rat sera were assessed using ELISA. Tight junction (TJ) proteins were detected by Western blotting. Results: In clinical study, the GI injury rate in mild acute pancreatitis (MAP), moderate severe acute pancreatitis (MSAP), and severe acute pancreatitis (SAP) groups was 26.8%, 78.4%, and 94.8%, respectively ( P < 0.05). Diamine oxidase (DAO), histidine decarboxylase (HDC), and matrix metalloproteinase 8 (MMP8) serum levels were higher in AP patients than in healthy people ( P < 0.05). Patients with GI injury had higher serum levels of DAO, HDC, and MMP8 than those without GI injury ( P < 0.05). In animal experiments, the serum levels of DAO, HDC, and MMP8 were higher in the AP group than in normal and sham-operated (SO) groups ( P < 0.05). The expressions of tricellulin, claudin-1, ZO-1, and occludin were significantly lower in the AP group than in normal and SO groups ( P < 0.05). Conclusion: The serum levels of DAO, HDC, and MMP8 are novel biomarkers of GI injury in the early stage of AP; their elevation indicates the development of GI injury in AP. The intestinal TJ disruption may be a primary mechanism of GI injury and requires more in-depth research. Keywords: gastrointestinal injury, acute pancreatitis, DAO, HDC, MMP8 Acute pancreatitis (AP) is among the most prevalent gastrointestinal (GI) conditions requiring hospitalization. It has a global incidence of ~34 per 100,000 person-years, 1 and studies indicate that the rate is increasing worldwide. 2 The updated Atlanta classification categorizes AP as mild, moderate, and severe. 3 Although the majority of people have mild acute pancreatitis (MAP), ~20% individuals develop moderate severe acute pancreatitis (MSAP) or severe acute pancreatitis (SAP) with pancreatic necrosis, peripancreatic tissue necrosis, and/or organ failure. 4,5 Intestinal mucosal barrier dysfunction is considered a major trigger of systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction (MOF) in AP patients, and intestinal barrier injury is a common complication in AP patients. 6 Intestinal bacterial translocation, pancreatic tissue necrosis and infection, and the beginning of multiple organ dysfunction syndrome are all caused by increased intestinal mucosal permeability. 7 However, Acute Physiology and Chronic Health Evaluation (APACHE) II and Sequential Organ Failure Assessment are two examples of current clinical scoring systems that have little efficacy in predicting the severity of AP. 8 The European Society of Intensive Care Medicine suggested the acute gastrointestinal injury (AGI) grade as more precise and detailed evaluation criteria. 9 The AGI grade can be used to assess the degree of GI damage and predict severity and adverse clinical outcomes in critical patients. 10 However, the AGI grade is a score criterion based on clinical presentation with some lag, and serum markers for early prediction of AGI are currently unclear. Several serum indicators may be used to predict AGI prognosis. Diamine oxidase (DAO), a cytoplasmic enzyme, is reportedly a reliable indicator of intestinal mucosal injury in both humans and rats. 11,12 The primary effect of histidine decarboxylase (HDC) is histamine production, which exhibits HDC activity in almost all adul -Abstract Truncated-
medicine, general & internal